CHRISTOPHER ALEXANDER DO NPI 1306850508

NPI Information

  • NPI: 1306850508
  • Provider Name: CHRISTOPHER ALEXANDER, DO
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 325 CLYDE MORRIS BLVD STE 450
    FLORIDA CANCER SPECIALISTS P L
    ORMOND BEACH, FL
    ZIP 32174
  • Phone: (386) 673-2442

Map and Directions

Get Directions

NPI Details

Christopher Alexander, DO is a medical oncology internal medicine in Ormond Beach, FL with 38 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Christopher Alexander, DO NPI is 1306850508. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: KANSAS CITY UNIVERSITY OF MED & BIOSCIENCES, COLLEGE OF OSTEO MED
Graduation Year:1988

The provider's business location address is:

325 CLYDE MORRIS BLVD STE 450
FLORIDA CANCER SPECIALISTS P L
ORMOND BEACH, FL
ZIP 32174-179
Phone: (386) 673-2442
Fax: (386) 673-4884

The NPI 1306850508 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Protein measurement, serum (HCPCS:84165)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Iron binding capacity (HCPCS:83550)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Folic acid level, serum (HCPCS:82746)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Blood test, clotting time (HCPCS:85610)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Magnesium level (HCPCS:83735)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood count, manual test (HCPCS:85044)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Automated urinalysis test (HCPCS:81003)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Vitamin d-3 level (HCPCS:82306)
  • Red blood count, automated test (HCPCS:85045)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Urinalysis, manual test (HCPCS:81002)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Rheumatoid factor level (HCPCS:86431)

The enumeration date for this NPI number is 7/27/2006 and was last updated on 3/24/2026.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyOS5715FLORIDANo
2207RX0202XInternal MedicineMedical OncologyOS5715FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1377924600MEDICAIDFLORIDA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.